A well-known international expert in cell therapy. Dr. Karnieli is the founder and former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy that was sold to Orgenesis Inc. in 2018.
Learn MoreA well-known international expert in cell therapy. Dr. Karnieli is the founder and former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy that was sold to Orgenesis Inc. in 2018. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP of the medical device at Goji solutions. Dr. Karnieli served as the chair of the process & product development committee of the International Society for Cellular Therapies, as an expert member in the ISO TC276 Biotechnology standard committee, and was the former chair of the science and technology committee of the Alliance for Regenerative Medicine.
Mr. Bercovich has over 19 years of cell therapy development and cGMP experience with extensive expertise in Bioreactor development. Mr. Bercovich was the former VP of Development of Atvio Biotech and the former
Learn MoreMr. Bercovich has over 19 years of cell therapy development and cGMP experience with extensive expertise in Bioreactor development. Mr. Bercovich was the former VP of Development of Atvio Biotech and the former Director of Process Engineering at Pluristem Therapeutics. Mr. Bercovichs vast and unique knowledge and experience in cell therapy bioreactor development and cGMP manufacturing is a critical asset for the company.
Ms. Hadar has over 20 years of experience in senior financial positions leading teams and organizations growth, managing M&A processes, financing rounds and reorganization activities. Ms. Hadar has a strong
Learn MoreMs. Hadar has over 20 years of experience in senior financial positions leading teams and organizations growth, managing M&A processes, financing rounds and reorganization activities. Ms. Hadar has a strong background in accounting, FP&A and international tax planning. Prior to joining Adva, Ms. Hadar was the group CFO of Gevasol, a privately held global industrial group, prior to that served as the CFO of two medical device start-ups that went through major acquisitions. Ms. Hadar is a certified public accountant, received her B.A in economics and accounting from the Haifa University, Master degree in Law studies from Bar Ilan University, and EMBA form Kellogg School of Management at Northwestern University.
Mrs. Toledo is a certified lawyer and holds an LLB from the Haifa University school of law. Additionally, Mrs. Toledo is a certified mediator. Prior to joining ADVA Biotechnology, Mrs. Toledo was the Business
Learn MoreMrs. Toledo is a certified lawyer and holds an LLB from the Haifa University school of law. Additionally, Mrs. Toledo is a certified mediator. Prior to joining ADVA Biotechnology, Mrs. Toledo was the Business Development Manager at Atvio Biotech ltd where she has built a global BD activity. Mrs. Toledo was part of the legal and IP department at Pluristem Therapeutics. Mrs. Toledo brings to the team expertise and experience in BD and marketing in cell therapy.
With a decade of experience in medical device executive management, Mr. Masad is well-versed in logistics, operations, and supply chain management. He has demonstrated success in leading and managing teams
Learn MoreWith a decade of experience in medical device executive management, Mr. Masad is well-versed in logistics, operations, and supply chain management. He has demonstrated success in leading and managing teams across various sectors and has a track record of building and implementing effective strategies and work procedures. Additionally, Mr. Masad holds a LLB and a B.A. in Government, Diplomacy, and Strategy from Reichman University (IDC Herzliya) and is a certified lawyer. He also serves as a lecturer on advanced logistics systems management at Technion - Israel Institute of Technology in Haifa, Israel. Mr. Masad's military background includes serving as a Major Rank Commander and Former Deputy Commander of the Paratroopers Commando Unit, bringing over 10 years of military experience to his professional endeavors.
Dr. Mahmoud Abuelhija is the product manager of the ADVA X3 system. Dr Abuelhija earned his PhD in microbiology and immunology from Ben Gurion University and did his post doc in MD Anderson cancer center. Dr.
Learn MoreDr. Mahmoud Abuelhija is the product manager of the ADVA X3 system. Dr Abuelhija earned his PhD in microbiology and immunology from Ben Gurion University and did his post doc in MD Anderson cancer center. Dr. Abuelhija has 10 years of experience in R&D of cell therapy device development. Dr. Abuelhija was the R&D manager at BioCEP technology, where he lead the development of a large-scale cell isolation device for IVF and cell therapy. Furthermore, Dr. Abuelhija has a unique blend of experience in medical devices and a valuable innovative nature taking part in several breakthrough inventions.
Mr. Abitbol is an experienced quality assurance leader in the field of biotechnology, medical equipment, and pathology. Mr. Abitbol holds B.Sc, Bachelor of Science from University of Haifa, and M.H.A, Master of
Learn MoreMr. Abitbol is an experienced quality assurance leader in the field of biotechnology, medical equipment, and pathology. Mr. Abitbol holds B.Sc, Bachelor of Science from University of Haifa, and M.H.A, Master of Healthcare Administration from Ben-Gurion University of the Negev. Mr. Abitbol is skilled in computer systems validation, equipment validation, employee management, and coordination. Extensive experience in drafting procedures, managing validations, and ensuring compliance with GLP/GMP standards. Proficient in DNA/RNA extractions, PCR, QPCR, and NGS library preparation. Mr. Abitbol has strong expertise and background in microbiology, including bioburden and endotoxin testing and validation. Effective communicator and collaborator with a track record of successful project delivery and process improvement.
Jessica Reilly is a creative and technically driven professional with over a decade of commercial experience in the evolving Advanced Therapy landscape.
Learn MoreJessica Reilly is a creative and technically driven professional with over a decade of commercial experience in the evolving Advanced Therapy landscape. Jessica Reilly has demonstrated success in implementing effective sales strategies and developing innovative technologies which earned her recognition in both research and sales throughout her career. Jessica Reilly is known for being an active participant of the biotechnology community, sharing her knowledge and experiences through guest lectures and publications. Jessica Reilly holds a Bachelors of Science in Bioengineering, in addition to multiple professional certificates. Her desire to continue learning and pushing boundaries has contributed to her success in the Biotechnology field.
Dr. Alona Feldman is the lab manager and senior scientist in the R&D group. She holds a PhD in Biology from the Technion Israel Institute of Technology and has over 5 years of experience in R&D within the
Learn MoreDr. Alona Feldman is the lab manager and senior scientist in the R&D group. She holds a PhD in Biology from the Technion Israel Institute of Technology and has over 5 years of experience in R&D within the cell therapy field. Dr. Feldman is also well-versed in endocrinology and stem cell research fields and has published extensively in top-tier journals.
Dr. Massri serves as Project Manager and Senior Scientist in Adva Biotechnology since 2021. Possess a unique educational background both as a Biotechnology engineer and a Biomedical scientist, having graduated
Learn MoreDr. Massri serves as Project Manager and Senior Scientist in Adva Biotechnology since 2021. Possess a unique educational background both as a Biotechnology engineer and a Biomedical scientist, having graduated (Cum Laude) from the Technion-Israel Institute of Technology with all three of his degrees. 10 years of hands-on expertise and scholarly contributions in realms such as molecular and cellular immunology, biochemistry, metabolomics, and cancer biology.
Mrs. Tayar brings more than 12 years of experience in cell therapy development and cGMP, coupled with a robust background in medical device development. She has particularly in-depth expertise gained from her
Learn MoreMrs. Tayar brings more than 12 years of experience in cell therapy development and cGMP, coupled with a robust background in medical device development. She has particularly in-depth expertise gained from her previous role involving the product development of a magnetic separation device within the cell therapy industry. Mrs. Tayar has been involved in every phase of the development process, from initial design and experimentation to the successful transformation into a fully functional market product. Additionally, her professional journey extends to meaningful contributions in breast and prostate research at Ziv Medical Hospital in Israel, highlighting her commitment to advancing medical knowledge and improving patient outcomes.
Dr. Paldus is the chair of Sekhmet Ventures and general partner of Skymoon Ventures. Former Founder, chairman, and CEO of Finesse Solutions Inc., a leading bioreactor company recently sold to ThermoFisher
Learn MoreDr. Paldus is the chair of Sekhmet Ventures and general partner of Skymoon Ventures. Former Founder, chairman, and CEO of Finesse Solutions Inc., a leading bioreactor company recently sold to ThermoFisher Scientific. Dr. Paldus was the former founder and CTO of Picarro. Dr. Paldus earned her Ph.D. in electronic engineering from Stanford University. Dr. Paldus has extensive understanding in the field of biotechnology, bioreactors, and strong and relevant business experience.
Neil Wallack has been a venture capital and private equity investor since 1992, with his most recent project, Aviv Growth Partners, involving the export of Israeli technology and know-how into large scale
Learn MoreNeil Wallack has been a venture capital and private equity investor since 1992, with his most recent project, Aviv Growth Partners, involving the export of Israeli technology and know-how into large scale commercial applications in the U.S. and global markets. Previously, Neil managed a multi-billion dollar private equity portfolio for the Ziff family in New York. Currently, Neil serves as an Officer of the Jewish Federations of North Americas Board; he is on the Board, Executive Committee and Israel Executive of the American Jewish Joint Distribution Committee (the Joint); and he is deeply involved with the Jewish Agency for Israel, among others.
Prof Ehninger was the former Head of Hematology and oncology at University Hospital Carl Gustav Carus of the Technical University Dresden, Germany as well the former President of the German Society of
Learn MoreProf Ehninger was the former Head of Hematology and oncology at University Hospital Carl Gustav Carus of the Technical University Dresden, Germany as well the former President of the German Society of Hematology and Oncology (DGHO). Gerhard has published more than 800 scientific articles in peer-reviewed journals and was the principal investigator for multiple pivotal studies in hematology and oncology. Gerhard is the founding and CEO of Cellex, a world leader in manufacturing cell products and a leading European CMO for CAR-T cells based in Cologne/Germany, and co-founder of the German Bone Marrow Donor Registry (DKMS).
Dr. Elazary is an experienced entrepreneur in the medical device and energy arena with over 30 approved patents. Dr. Elazary is the founder of several companies in the field of medical devices and an advisor
Learn MoreDr. Elazary is an experienced entrepreneur in the medical device and energy arena with over 30 approved patents. Dr. Elazary is the founder of several companies in the field of medical devices and an advisor and board member of over ten medical device companies. Dr. Elazarys experience and creative thinking provides the company guidance and expertise and
Prof Karnieli is a professor of medicine at the Technicon Institute, a world-known expert in Endocrinology and personalized medicine. Chair of several international and Israeli medical societies in
Learn MoreProf Karnieli is a professor of medicine at the Technicon Institute, a world-known expert in Endocrinology and personalized medicine. Chair of several international and Israeli medical societies in Endocrinology, Telemedicine, and Personalized Medicine. Head of the Galil center for telemedicine and an advisor to many of the large pharma on personalized medicine and endocrinology. Over 100 pear reviewed papers and books and several on cell & gene therapy
Have any questions? Reach out to us from our contact form and we will get back to you shortly.